Finally, we analyzed the relationship between EGFR mutation status detected in pcfDNA and scfDNA and clinical treatment response in the 27 NSCLC patients whose tumors harbored common EGFR mutations which were confirmed by tissue biopsy. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.